Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Stereotactic Hypofractionated Radiotherapy of the Prostate

NCT01540994 is registered in ClinicalTrials.gov with Sharp HealthCare as lead sponsor.

NCT NCT01540994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01540994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Stereotactic Hypofractionated Radiotherapy of the Prostate
Lead sponsor
Sharp HealthCare
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
April 5, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasm